97在线无码免费人妻短视频,国产成人成人A片在线乱码视频,欧美肥老太牲交视频,国产精品爽爽v在线观看无码

English

ENDPOINTSNEWS: On a quest to challenge Novo Nordisk in obesity, transpacific startup picks up $70M — and a pair of seasoned execs

2021-10-13

新聞截圖.png

— AUTHOR: Amber Tong, Senior Editor

— REPRINTED FROM ENDPOINTSNEWS

— ORIGINAL LINK: https://endpts.com/on-a-quest-to-challenge-novo-nordisk-in-obesity-transpacific-startup-picks-up-70m-and-a-pair-of-seasoned-execs/

Four years after starting Terns Pharmaceuticals together in search of an elusive NASH win, Weidong Zhong and Martijn Fenaux are reuniting at a new startup.

On paper, Sciwind Biosciences — which just raised $70 million in Series C cash — employs a similar setup as Terns: Both have embraced the transpacific model, taking root in China but planting flags in the US.

Zhong was tapped to be president of the San Francisco-based subsidiary back in July, on top of assuming the role as chief strategy officer. Weeks later, Fenaux has been appointed SVP, nonclinical development and translational science at the parent company out of Hangzhou — joining the team alongside chief scientific officer Xinle Wu, who brings experience running R&D for both Eli Lilly and Amgen in China.

Whereas Terns is focused on NASH and other liver diseases, Sciwind positions itself as a specialist in metabolic disorders. The three lead candidates all congregate around GLP-1 receptor agonism, a mechanism that Sciwind reckons is relevant across fatty liver, obesity and diabetes.

The new infusion marks Sciwind’s second financing in a year, having bagged $37 million in February to fuel the clinical work underway for XW003 (long-acting GLP-1 peptide analog) in type 2 diabetes and obesity. Topline Phase II data are expected in the second half of 2022.

To reach those massive markets, the biotech would first have to steer past giant rivals like Novo Nordisk, whose GLP-1 peptide analog semaglutide is already approved in the US for both of those indications.

Then there's the follow-on XW004, which is designed for once daily rather than once weekly administration, slated for first-in-human trials later this year; and XW014, a preclinical small molecule GLP-1R agonist.

But IDG Capital, Loyal Valley Capital and LYFE Capital have no trouble believing in Sciwind and founder/CEO Hai Pan, leading the latest round.

黑人巨大vⅰdous娇小 | 国产精品99精品久久免费 | 另类老妇性BBwBBw | 亚洲熟妇无码Av无码www | 日本91无码精品秘 入口 | 狂野欧美日韩中文字幕一区 | 日韩一区在线视频看看 | 国产视频一区二区在线 | 国产午夜免费视频在线观看 | 国产精伦一区二区成人午夜精品 | 四虎成人免费视频 | 亚洲欧洲精品一区二区三区 | 懂色aⅴ一区二区三区免费 人妻体内射精一区二区三区 | 国产黄A三级三级三级老师 农村寡妇高潮一级A片视频 | 国产精品成人A片在线果冻 91嫩草国产婷婷二区三区 | 精品熟女少妇Av免费观看 | 国产精品久久久精品三级无码 | 人人操欧美两性视 | 日本黄色大片咪咪爱 | 开心激情四射天堂网 | 黑人巨大猛交丰满少妇 | 女主播大尺度色诱视频免费观看 | 性一交一乱一A片熟女 | 中文字幕精品一区二区三区精品 | 丁香五月天在线视频 | 欧美老妇又粗又大 | 蜜桃av鲁一鲁一鲁一鲁樱花影院 | 无码人妻丰满熟妇一区二区三区 | aa黄色欧美一级大片 | 男女午夜人成视频 | 国际精品iGAO为爱寻找激情视频 | 中午字幕av影音先锋在线观看 | 亚洲无码在线视频一区二区 | 日本不卡在线观看 | 四川BBB搡BBB爽爽视频 | 爱妻艺免费观看视频一区二区三区 | 强奸轮奸电影久久电影欧美电影 | 国产精品久久人妻朋友黄牛影视 | 亚洲无码在线视频网站 | 国产第一午夜福利在线 | 亚洲AV无码久久精品国产一区 |